- Epinephrine in a patient on a non-selective beta-blocker:
- The dental drug interaction: unopposed alpha-1 vasoconstriction with reflex bradycardia, cardioselective vs non-selective, and the 0.04 mg cap.
- Pilocarpine for xerostomia in Sjögren syndrome:
- Muscarinic agonism (M3) to drive salivary flow, side effects (sweat, GI), contraindications (asthma, glaucoma, bradycardia), and cevimeline as an alternative.
- Albuterol for an asthma exacerbation:
- Selective beta-2 agonism to bronchodilate, high-dose tachycardia/tremor, ipratropium contrast, and the propranolol caveat.
- Atropine for symptomatic bradycardia:
- Muscarinic blockade at the SA node, anticholinergic side effects in the elderly, glycopyrrolate as a peripheral alternative, and atropine + pralidoxime for organophosphates.
- Choosing a vasoconstrictor for a cardiac patient:
- Alpha-1 vasoconstriction, the cardiac cap (~0.04 mg), phenylephrine as pure alpha-1, deferring unstable angina, and cardioselective beta-blocker safety.
- Cholinergic crisis from too much pyridostigmine:
- AChEI overdose, the DUMBBELS/SLUDGE picture, atropine as antidote, pralidoxime for organophosphates, and distinguishing from myasthenic crisis.
- Dry mouth from anticholinergic medications:
- Polypharmacy with anticholinergic burden, classic anticholinergic side effects, fluoride and salivary substitutes, and pilocarpine/cevimeline as rescue.
- Clonidine and rebound hypertension:
- Central alpha-2 agonism, rebound on abrupt cessation, dexmedetomidine and methyldopa as relatives, and capped epinephrine when stable.